Lockshin Curtis bought PHIO
February 5, 2026 · Form 4 insider transaction
Lockshin Curtis bought 16,600 shares of Phio Pharmaceuticals Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,600
Price
$0.00
Total value
N/A
InsiderLockshin Curtis
Role—
SecurityCommon Stock, $.0001 par value
Transaction codeA: Grant or award
Transaction dateFebruary 5, 2026
Filing dateFebruary 6, 2026
Shares owned after35,155
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.; Includes shares of common stock underlying unvested restricted stock units.; The number of reported securities has been adjusted to reflect prior reverse stock splits.